• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

绝经前晚期雌激素阳性或/和孕激素阳性乳腺癌女性的治疗：手术去势与促性腺激素释放激素类似物（诺雷德）对比

Therapy in premenopausal women with advanced, oestrogen positive or/and progesterone positive breast cancer: surgical oophorectomy versus the LHRH analogue, Zoladex.

作者信息

Robert N J, Dalton W S, Osborne C K, Abeloff M

机构信息

Southwest Oncology Group, New England Medical Center, Boston, Mass.

出版信息

Horm Res. 1989;32 Suppl 1:221-2. doi: 10.1159/000181351.

DOI:10.1159/000181351
PMID:2533155
Abstract

The basis and design of a trial that will compare surgical oophorectomy with the LHRH analogue, Zoladex, in the treatment of premenopausal women with advanced, oestrogen receptor-positive or progesterone receptor-positive breast cancer, is described.

摘要

本文描述了一项试验的基础和设计，该试验将比较手术卵巢切除术与促性腺激素释放激素类似物（诺雷德）在治疗绝经前、雌激素受体阳性或孕激素受体阳性的晚期乳腺癌女性中的效果。

相似文献

1
Therapy in premenopausal women with advanced, oestrogen positive or/and progesterone positive breast cancer: surgical oophorectomy versus the LHRH analogue, Zoladex.绝经前晚期雌激素阳性或/和孕激素阳性乳腺癌女性的治疗：手术去势与促性腺激素释放激素类似物（诺雷德）对比
Horm Res. 1989;32 Suppl 1:221-2. doi: 10.1159/000181351.
2
Zoladex in advanced breast cancer.
Horm Res. 1989;32 Suppl 1:206-8. doi: 10.1159/000181347.
3
Effect of LHRH agonist, Zoladex, on ovarian histology.促黄体生成素释放激素（LHRH）激动剂戈舍瑞林对卵巢组织学的影响。
Br J Surg. 1988 Jun;75(6):595-6. doi: 10.1002/bjs.1800750634.
4
A multi-centre randomised study to compare the effects of ovarian ablation with Zoladex depot in pre- and perimenopausal patients with advanced breast cancer.一项多中心随机研究，比较戈舍瑞林长效注射剂卵巢去势对绝经前和围绝经期晚期乳腺癌患者的疗效。
Horm Res. 1989;32 Suppl 1:218-20. doi: 10.1159/000181350.
5
Medical castration with zoladex: a conservative approach to premenopausal breast cancer.
Tumori. 1991 Apr 30;77(2):145-50. doi: 10.1177/030089169107700211.
6
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group.戈舍瑞林，一种长效促性腺激素释放激素激动剂，用于治疗绝经前转移性乳腺癌患者。德国诺雷德试验组。
J Clin Oncol. 1989 Aug;7(8):1113-9. doi: 10.1200/JCO.1989.7.8.1113.
7
Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival.戈舍瑞林（诺雷德）用于绝经前晚期乳腺癌：缓解持续时间和生存期
Br J Cancer. 1990 Nov;62(5):868-70. doi: 10.1038/bjc.1990.397.
8
The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer.促黄体生成素释放激素激动剂（ICI 118630，诺雷德）在绝经前晚期乳腺癌中的应用。
Br J Cancer. 1986 May;53(5):629-36. doi: 10.1038/bjc.1986.106.
9
The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.4-羟基雄烯二酮单独及联合戈舍瑞林对绝经前晚期乳腺癌女性的临床及内分泌影响。
Br J Cancer. 1990 Oct;62(4):679-83. doi: 10.1038/bjc.1990.356.
10
Review of the endocrine actions of luteinising hormone-releasing hormone analogues in premenopausal women with breast cancer.
Horm Res. 1989;32 Suppl 1:198-201. doi: 10.1159/000181345.

引用本文的文献

1
Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions.戈舍瑞林。对其药效学和药代动力学特性以及在性激素相关病症中的临床应用的综述。
Drugs. 1991 Feb;41(2):254-88. doi: 10.2165/00003495-199141020-00008.